'Cv death' presentation slideshows

9-11 MAGGIO 2014

1.09k views • 87 slides

Luigi Oltrona Visconti Divisione di Cardiologia IRCCS Fondazione Policlinico S. Matteo Pavia

897 views • 73 slides

588 views • 46 slides

CHARM Program: 3 Component trials comparing candesartan with placebo

CHARM Program: 3 Component trials comparing candesartan with placebo. CHARM Program: Baseline characteristics. CHARM Program: Baseline medications. CHARM-Overall: CV death and non-CV death. CHARM Program: Reduction in mortality and morbidity. CHARM Program: Reduction in CHF hospitalization.

992 views • 46 slides

Patient Oriented Therapy for STE-MI

550 views • 45 slides

Statin in Acute Coronary Syndrome

Statin in Acute Coronary Syndrome. By C. Wongvipaporn Division Cardiology, Medicine Department Faculty of Medicine, Khon Kaen University. Acute Myocardial Infarction. AMI is fatal in about 30-50% of cases Approximately 50% of AMI deaths occur within 1 hour of symptom onset.

2.66k views • 43 slides

Prediabetes

Prediabetes. Comorbidities and Complications. Common Comorbidities of Prediabetes. Obesity CVD Dyslipidemia Hypertension. Renal failure Cancer Sleep disorders. Handelsman Y, et al. Endocr Pract . 2011;17(suppl 2):1-53. . Clinical Risks of Not Treating Prediabetes Are Substantial.

795 views • 43 slides

Should we Monitor Anti-Platelet Treatment?

Should we Monitor Anti-Platelet Treatment?. Rabih R. Azar, MD, MSc, FACC Director of Cardiovascular Research Hotel Dieu de France Hospital Associate Professor of Medicine Saint Joseph University School of Medicine. Should we Monitor Anti-Platelet Treatment?.

857 views • 42 slides

Should we Monitor Anti-Platelet Treatment?

Should we Monitor Anti-Platelet Treatment?. Rabih R. Azar, MD, MSc, FACC Director of Cardiovascular Research Hotel Dieu de France Hospital Associate Professor of Medicine Saint Joseph University School of Medicine. Should we Monitor Anti-Platelet Treatment?.

673 views • 42 slides

614 views • 42 slides

449 views • 30 slides

Welcome Cara Bilinsky ACCELMED

Welcome Cara Bilinsky ACCELMED. Logistical Information. Track Number: Track 1 = Red travel packet Track 2 = Blue travel packet Departure: Departure city = city on ID Rotation: You will rotate sessions every 25 minutes 5-minute transition time between sessions.

404 views • 27 slides

Cardiovascular Safety of Linagliptin

Cardiovascular Safety of Linagliptin. Rafael Castillo, MD, FPCP, FPCC PHA Scientific Sessions Crowne Plaza Hotel May 24, 2012. DISCLOSURES.

1.26k views • 24 slides

TRITON-TIMI 38 AHA 2007 Orlando, Florida

TR ial to Assess I mprovement in T herapeutic Outcomes by O ptimizing Platelet Inhibitio N with Prasugrel. TRITON-TIMI 38 AHA 2007 Orlando, Florida.

555 views • 24 slides

TRANSCEND

TRANSCEND: T elmisartan R andomized A ssesme N t S tudy in a CE i N tolerant S ubjects with C ardiovascular D isease. TRANSCEND. Question: Is telmisartan superior to placebo in patients at high risk of CV events who are intolerant of ACE-I? Outcome:

486 views • 22 slides

Program outline

409 views • 22 slides

Disclosures

EFFECT OF THE DIRECT RENIN INHIBITOR ALISKIREN ON LEFT VENTRICULAR REMODELING FOLLOWING MYOCARDIAL INFARCTION WITH LEFT VENTRICULAR DYSFUNCTION.

335 views • 21 slides

TRACER: Design

Key inclusion criteria Within 24 hrs of symptoms ? biomarkers or ECG changes 1 other high-risk feature. NSTE Acute Coronary Syndromes. 1:1 Randomized Double-blind. Placebo. Vorapaxar. Loading: 40 mg Maintenance: 2.5 mg daily. Follow-up: 1, 4, 8, 12 months, then every 6 months

269 views • 7 slides

STICH CABG

STICH CABG. Objective To determine whether surgery plus medical management or medical management alone improve outcomes in CABG patients Study Design

419 views • 3 slides

STEMI PATIENT ELIGIBLE FOR PPCI

Overall ERIC-PPCI study design summary. STEMI PATIENT ELIGIBLE FOR PPCI. PPCI centre. RANDOMISATION 1:1. RIC 4x5 min arm cuff 200mmHg inflations/deflations. SHAM RIC 4x5 min arm cuff 10mmHg inflations/deflations. PPCI PROCEDURE 1xblood sample taken (hsTropT, CK-MB). Cardiac catheter lab.

160 views • 1 slides